Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 160 Pages
Report ld: 4806396
Request Sample
Customized Report
Assisted Reproductive Apparatus Market Size(US$)

CAGR 2025-2031
12.4%
Market Size,2031
USD 4,703
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Assisted Reproductive Apparatus market is projected to grow from US$ 2098 million in 2024 to US$ 4703 million by 2031, at a CAGR of 12.4% (2025-2031), driven by critical product segments and diverse end‑use applications.
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Global key players of Assisted Reproductive Apparatus include CooperSurgical, Vitrolife, Cook Medical and Olympus, etc. The top four players hold a share about 50%. China is the largest market, has a share about 50%. In terms of product type, Consumables and Surgical Devices is the largest segment, occupied for a share of about 40%, and in terms of application, Hospitals has a share about 55 percent.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Assisted Reproductive Apparatus market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Assisted Reproductive Apparatus study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Assisted Reproductive Apparatus: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Assisted Reproductive Apparatus Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Liquid Products
1.2.3 Consumables and Surgical Devices
1.2.4 Special Instrument
1.3 Market Segmentation by Application
1.3.1 Global Assisted Reproductive Apparatus Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics and Fertility Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Assisted Reproductive Apparatus Revenue Estimates and Forecasts 2020-2031
2.2 Global Assisted Reproductive Apparatus Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Assisted Reproductive Apparatus Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Assisted Reproductive Apparatus Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Liquid Products Market Size by Players
3.3.2 Consumables and Surgical Devices Market Size by Players
3.3.3 Special Instrument Market Size by Players
3.4 Global Assisted Reproductive Apparatus Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Assisted Reproductive Apparatus Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Assisted Reproductive Apparatus Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Assisted Reproductive Apparatus Market Size by Type (2020-2031)
6.4 North America Assisted Reproductive Apparatus Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Assisted Reproductive Apparatus Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Assisted Reproductive Apparatus Market Size by Type (2020-2031)
7.4 Europe Assisted Reproductive Apparatus Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Assisted Reproductive Apparatus Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Assisted Reproductive Apparatus Market Size by Type (2020-2031)
8.4 Asia-Pacific Assisted Reproductive Apparatus Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Assisted Reproductive Apparatus Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Assisted Reproductive Apparatus Market Size by Type (2020-2031)
9.4 Central and South America Assisted Reproductive Apparatus Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Assisted Reproductive Apparatus Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Assisted Reproductive Apparatus Market Size by Type (2020-2031)
10.4 Middle East and Africa Assisted Reproductive Apparatus Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Assisted Reproductive Apparatus Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 CooperSurgical
11.1.1 CooperSurgical Corporation Information
11.1.2 CooperSurgical Business Overview
11.1.3 CooperSurgical Assisted Reproductive Apparatus Product Features and Attributes
11.1.4 CooperSurgical Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.1.5 CooperSurgical Assisted Reproductive Apparatus Revenue by Product in 2024
11.1.6 CooperSurgical Assisted Reproductive Apparatus Revenue by Application in 2024
11.1.7 CooperSurgical Assisted Reproductive Apparatus Revenue by Geographic Area in 2024
11.1.8 CooperSurgical Assisted Reproductive Apparatus SWOT Analysis
11.1.9 CooperSurgical Recent Developments
11.2 Vitrolife
11.2.1 Vitrolife Corporation Information
11.2.2 Vitrolife Business Overview
11.2.3 Vitrolife Assisted Reproductive Apparatus Product Features and Attributes
11.2.4 Vitrolife Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.2.5 Vitrolife Assisted Reproductive Apparatus Revenue by Product in 2024
11.2.6 Vitrolife Assisted Reproductive Apparatus Revenue by Application in 2024
11.2.7 Vitrolife Assisted Reproductive Apparatus Revenue by Geographic Area in 2024
11.2.8 Vitrolife Assisted Reproductive Apparatus SWOT Analysis
11.2.9 Vitrolife Recent Developments
11.3 Cook Medical
11.3.1 Cook Medical Corporation Information
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Assisted Reproductive Apparatus Product Features and Attributes
11.3.4 Cook Medical Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.3.5 Cook Medical Assisted Reproductive Apparatus Revenue by Product in 2024
11.3.6 Cook Medical Assisted Reproductive Apparatus Revenue by Application in 2024
11.3.7 Cook Medical Assisted Reproductive Apparatus Revenue by Geographic Area in 2024
11.3.8 Cook Medical Assisted Reproductive Apparatus SWOT Analysis
11.3.9 Cook Medical Recent Developments
11.4 Olympus
11.4.1 Olympus Corporation Information
11.4.2 Olympus Business Overview
11.4.3 Olympus Assisted Reproductive Apparatus Product Features and Attributes
11.4.4 Olympus Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.4.5 Olympus Assisted Reproductive Apparatus Revenue by Product in 2024
11.4.6 Olympus Assisted Reproductive Apparatus Revenue by Application in 2024
11.4.7 Olympus Assisted Reproductive Apparatus Revenue by Geographic Area in 2024
11.4.8 Olympus Assisted Reproductive Apparatus SWOT Analysis
11.4.9 Olympus Recent Developments
11.5 Nikon
11.5.1 Nikon Corporation Information
11.5.2 Nikon Business Overview
11.5.3 Nikon Assisted Reproductive Apparatus Product Features and Attributes
11.5.4 Nikon Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.5.5 Nikon Assisted Reproductive Apparatus Revenue by Product in 2024
11.5.6 Nikon Assisted Reproductive Apparatus Revenue by Application in 2024
11.5.7 Nikon Assisted Reproductive Apparatus Revenue by Geographic Area in 2024
11.5.8 Nikon Assisted Reproductive Apparatus SWOT Analysis
11.5.9 Nikon Recent Developments
11.6 Zeiss
11.6.1 Zeiss Corporation Information
11.6.2 Zeiss Business Overview
11.6.3 Zeiss Assisted Reproductive Apparatus Product Features and Attributes
11.6.4 Zeiss Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.6.5 Zeiss Recent Developments
11.7 FUJIFILM Irvine Scientific
11.7.1 FUJIFILM Irvine Scientific Corporation Information
11.7.2 FUJIFILM Irvine Scientific Business Overview
11.7.3 FUJIFILM Irvine Scientific Assisted Reproductive Apparatus Product Features and Attributes
11.7.4 FUJIFILM Irvine Scientific Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.7.5 FUJIFILM Irvine Scientific Recent Developments
11.8 Kitazato
11.8.1 Kitazato Corporation Information
11.8.2 Kitazato Business Overview
11.8.3 Kitazato Assisted Reproductive Apparatus Product Features and Attributes
11.8.4 Kitazato Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.8.5 Kitazato Recent Developments
11.9 Leica Microsystems
11.9.1 Leica Microsystems Corporation Information
11.9.2 Leica Microsystems Business Overview
11.9.3 Leica Microsystems Assisted Reproductive Apparatus Product Features and Attributes
11.9.4 Leica Microsystems Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.9.5 Leica Microsystems Recent Developments
11.10 Genea Biomedx
11.10.1 Genea Biomedx Corporation Information
11.10.2 Genea Biomedx Business Overview
11.10.3 Genea Biomedx Assisted Reproductive Apparatus Product Features and Attributes
11.10.4 Genea Biomedx Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 CORNING
11.11.1 CORNING Corporation Information
11.11.2 CORNING Business Overview
11.11.3 CORNING Assisted Reproductive Apparatus Product Features and Attributes
11.11.4 CORNING Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.11.5 CORNING Recent Developments
11.12 Basecare Medical
11.12.1 Basecare Medical Corporation Information
11.12.2 Basecare Medical Business Overview
11.12.3 Basecare Medical Assisted Reproductive Apparatus Product Features and Attributes
11.12.4 Basecare Medical Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.12.5 Basecare Medical Recent Developments
11.13 Esco Lifesciences Group
11.13.1 Esco Lifesciences Group Corporation Information
11.13.2 Esco Lifesciences Group Business Overview
11.13.3 Esco Lifesciences Group Assisted Reproductive Apparatus Product Features and Attributes
11.13.4 Esco Lifesciences Group Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.13.5 Esco Lifesciences Group Recent Developments
11.14 WEGO
11.14.1 WEGO Corporation Information
11.14.2 WEGO Business Overview
11.14.3 WEGO Assisted Reproductive Apparatus Product Features and Attributes
11.14.4 WEGO Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.14.5 WEGO Recent Developments
11.15 Prodimed S.A.S
11.15.1 Prodimed S.A.S Corporation Information
11.15.2 Prodimed S.A.S Business Overview
11.15.3 Prodimed S.A.S Assisted Reproductive Apparatus Product Features and Attributes
11.15.4 Prodimed S.A.S Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.15.5 Prodimed S.A.S Recent Developments
11.16 FertiPro
11.16.1 FertiPro Corporation Information
11.16.2 FertiPro Business Overview
11.16.3 FertiPro Assisted Reproductive Apparatus Product Features and Attributes
11.16.4 FertiPro Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.16.5 FertiPro Recent Developments
11.17 Bred Life Science Technology Inc
11.17.1 Bred Life Science Technology Inc Corporation Information
11.17.2 Bred Life Science Technology Inc Business Overview
11.17.3 Bred Life Science Technology Inc Assisted Reproductive Apparatus Product Features and Attributes
11.17.4 Bred Life Science Technology Inc Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.17.5 Bred Life Science Technology Inc Recent Developments
11.18 Changhong Technology (Boomingshing Medical and Liyin Precision Medical)
11.18.1 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Corporation Information
11.18.2 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Business Overview
11.18.3 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Assisted Reproductive Apparatus Product Features and Attributes
11.18.4 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.18.5 Changhong Technology (Boomingshing Medical and Liyin Precision Medical) Recent Developments
11.19 Gynetics Medical Products
11.19.1 Gynetics Medical Products Corporation Information
11.19.2 Gynetics Medical Products Business Overview
11.19.3 Gynetics Medical Products Assisted Reproductive Apparatus Product Features and Attributes
11.19.4 Gynetics Medical Products Assisted Reproductive Apparatus Revenue and Gross Margin (2020-2025)
11.19.5 Gynetics Medical Products Recent Developments
12 Assisted Reproductive ApparatusIndustry Chain Analysis
12.1 Assisted Reproductive Apparatus Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Assisted Reproductive Apparatus Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Assisted Reproductive Apparatus Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Assisted Reproductive Apparatus market size was US$ 2332 million in 2025 and is forecast to reach a readjusted size of US$ 5228 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 101
USD 4250.00
(Single User License)
The global Assisted Reproductive Apparatus market was valued at US$ 2332 million in 2025 and is anticipated to reach US$ 5228 million by 2032, at a CAGR of 12.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 138
USD 2900.00
(Single User License)
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2332 million in 2025 and is projected to reach US$ 5228 million, growing at a CAGR of 12.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 123
USD 3950.00
(Single User License)
The global Assisted Reproductive Apparatus market size was US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 104
USD 4250.00
(Single User License)
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published Date: 2025-01-19
Pages: 123
USD 3950.00
(Single User License)
The global market for Assisted Reproductive Apparatus was valued at US$ 2098 million in the year 2024 and is projected to reach a revised size of US$ 4703 million by 2031, growing at a CAGR of 12.4% during the forecast period.
Published Date: 2025-01-19
Pages: 96
USD 2900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-17
Pages: 175
USD 5600.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-16
Pages: 171
USD 5900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-04-07
Pages: 110
USD 4900.00
(Single User License)
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published Date: 2024-01-18
Pages: 123
USD 3950.00
(Single User License)
The global Assisted Reproductive Apparatus market size was US$ 2332 million in 2025 and is forecast to reach a readjusted size of US$ 5228 million by 2032 with a CAGR of 12.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 101
The global Assisted Reproductive Apparatus market was valued at US$ 2332 million in 2025 and is anticipated to reach US$ 5228 million by 2032, at a CAGR of 12.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 138
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2332 million in 2025 and is projected to reach US$ 5228 million, growing at a CAGR of 12.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 123
The global Assisted Reproductive Apparatus market size was US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 104
The global market for Assisted Reproductive Apparatus was estimated to be worth US$ 2098 million in 2024 and is forecast to a readjusted size of US$ 4703 million by 2031 with a CAGR of 12.4% during the forecast period 2025-2031.
Published: 2025-01-19
Pages: 123
The global market for Assisted Reproductive Apparatus was valued at US$ 2098 million in the year 2024 and is projected to reach a revised size of US$ 4703 million by 2031, growing at a CAGR of 12.4% during the forecast period.
Published: 2025-01-19
Pages: 96
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-17
Pages: 175
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-16
Pages: 171
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-04-07
Pages: 110
Assisted reproduction is the assistance provided to address infertility. All treatments of fertility in which handling of both egg and embryo is done are included in “assisted reproductive techniques (ARTs).” In these techniques, eggs from woman’s ovaries are surgically removed and combined in vitro with sperm and embryo is ultimatly returned to the uterine cavity. ARTs therefore incorporate a wide range of procedures that are used to overcome natural barriers in fertilization by directly collecting and in vitro handling of human gametes and replacement of embryo into the uterus.
Published: 2024-01-18
Pages: 123
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now